Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1197917019 | Central alpha-adrenoceptor agonist (substance) | en | Fully specified name | Inactive | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 1211152010 | Central alpha-adrenoceptor agonist | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3646033017 | Substance with central alpha adrenergic receptor agonist mechanism of action (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3646034011 | Substance with central alpha adrenergic receptor agonist mechanism of action | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Substance with central alpha adrenergic receptor agonist mechanism of action | Is a | Sympathomimetic agent (substance) | false | Inferred relationship | Some | ||
| Substance with central alpha adrenergic receptor agonist mechanism of action | Is a | Alpha adrenergic receptor agonist | false | Inferred relationship | Some | ||
| Substance with central alpha adrenergic receptor agonist mechanism of action | Has disposition (attribute) | Alpha adrenergic receptor agonist (disposition) | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Apraclonidine hydrochloride | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Guanfacine (substance) | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Guanabenz (substance) | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Methyldopa (substance) | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Central alpha-adrenoceptor agonist poisoning | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | 1 |
| Accidental clonidine poisoning | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Intentional clonidine poisoning | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| intoxication par la clonidine d'intention indéterminée | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Central alpha-adrenoceptor agonist adverse reaction | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Apraclonidine adverse reaction | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine adverse reaction | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Lofexidine adverse reaction | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Central alpha-adrenoceptor agonist allergy | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Allergy to apraclonidine (finding) | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Allergy to clonidine (finding) | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Allergy to lofexidine (finding) | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Central alpha-adrenoceptor agonist overdose | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | 1 |
| Clonidine overdose | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Accidental clonidine overdose | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Intentional clonidine overdose | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| surdose de clonidine d'intention indéterminée | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride [antihypertensive] | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride 250micrograms m/r capsule | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| chlorhydrate de clonidine 150 microgrammes/mL, ampoule de 1 mL de solution pour injection | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine HCl [migraine] | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Product containing precisely clonidine hydrochloride 25 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Lofexidine hydrochloride | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Lofexidine hydrochloride 200 microgram oral tablet | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Product containing apraclonidine (medicinal product) | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Product containing central alpha-adrenoceptor agonist | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | 1 |
| Product containing lofexidine (medicinal product) | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride 0.1mg tablet | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride 200 microgram oral tablet | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride 0.3mg tablet | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine 2.5mg/unt | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine 7.5mg/unt | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride 100mcg/mL injection | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine 4mg/patch | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine 0.1mg patch | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine 5mg patch | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Chlortalidone 15 mg and clonidine hydrochloride 200 microgram oral tablet | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Product containing precisely chlortalidone 15 milligram and clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine-containing product in oral dose form | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine-containing product in transdermal dose form | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Product containing clonidine in parenteral dose form (medicinal product form) | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine m/r | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Poisoning by clonidine | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Product containing clonidine (medicinal product) | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Apraclonidine hydrochloride 1%/mL solution | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Apraclonidine hydrochloride 0.5% solution | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Product containing chlortalidone and clonidine hydrochloride | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride 100mcg/mL injection solution 10mL vial | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride 100 microgram oral tablet | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Product containing precisely clonidine hydrochloride 300 microgram/1 each conventional release oral tablet (clinical drug) | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Apraclonidine (as apraclonidine hydrochloride) 5 mg/mL eye drops | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Apraclonidine 1% intra-ocular solution | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Apraclonidine hydrochloride | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride 0.5mg/mL injection solution 10mL vial | Has active ingredient | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine (substance) | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Lofexidine (substance) | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Central alpha-adrenoceptor agonist allergy | Causative agent | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | 1 |
| Lofexidine hydrochloride (substance) | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Clonidine hydrochloride (substance) | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Methyldopa anhydrous | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Guanfacine hydrochloride (substance) | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some | |
| Guanabenz acetate | Is a | False | Substance with central alpha adrenergic receptor agonist mechanism of action | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)